FDA Inspection 1087221 — Shandong Xinhua Pharmaceutical Company Limited Hutian Branch
The FDA completed an inspection of Shandong Xinhua Pharmaceutical Company Limited Hutian Branch on March 29, 2019 in Zibo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 29, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Zibo (China)